tiprankstipranks
Trending News
More News >
Ocumension Therapeutics (HK:1477)
:1477
Hong Kong Market
Advertisement

Ocumension Therapeutics (1477) Income Statement

Compare
1 Followers

Ocumension Therapeutics Income Statement

Last quarter (Q4 2024), Ocumension Therapeutics's total revenue was ¥249.68M, an increase of 139.11% from the same quarter last year. In Q4, Ocumension Therapeutics's net income was ¥-116.93M. See Ocumension Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 417.31M¥ 246.37M¥ 158.96M¥ 56.15M¥ 13.10M
Gross Profit
¥ 225.06M¥ 144.37M¥ 102.92M¥ 36.94M¥ 11.37M
Operating Expenses
¥ 529.14M¥ 546.51M¥ 551.14M¥ 422.48M¥ 499.20M
Depreciation and Amortization
¥ 88.61M¥ 57.54M¥ 40.46M¥ 13.90M¥ 4.65M
EBITDA
¥ -260.05M¥ -320.62M¥ -359.98M¥ -371.30M¥ -2.26B
Operating Income
¥ -306.43M¥ -402.15M¥ -397.23M¥ -385.20M¥ -2.27B
Other Income/Expenses
¥ 39.17M¥ 22.67M¥ -5.00M¥ 125.55M¥ -1.78B
Pretax Income
¥ -267.26M¥ -379.48M¥ -402.23M¥ -259.99M¥ -2.26B
Net Income
¥ -268.27M¥ -379.79M¥ -402.64M¥ -134.78M¥ -2.26B
Per Share Metrics
Basic EPS
¥ -0.39¥ -0.59¥ -0.64¥ -0.22¥ -7.47
Diluted EPS
¥ -0.39¥ -0.59¥ -0.64¥ -0.22¥ -7.47
Weighted Average Shares Outstanding
687.88M 649.19M 632.53M 607.14M 302.35M
Weighted Average Shares Outstanding (Diluted)
687.88M 649.19M 632.53M 607.14M 302.35M
Currency in CNY

Ocumension Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis